Niall J OSullivan
Overview
Explore the profile of Niall J OSullivan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
OSullivan N, Tohidinezhad F, Temperley H, Ajredini M, Sokmen B, Atabey R, et al.
Cancer Med
. 2025 Feb;
14(4):e70699.
PMID: 39967347
Introduction: Local recurrence and distant metastasis remain a concern in advanced rectal cancer, with up to 10% and 20%-30% of patients suffering local and distal progression, respectively. Radiomics refers to...
2.
Temperley H, Hylands A, OSullivan N, Mac Curtain B, Temperley T, Waters C, et al.
Ir J Med Sci
. 2024 Dec;
194(1):19-29.
PMID: 39627625
This narrative review provides a comprehensive overview of complications in interventional radiology (IR), focusing on their aetiology, recognition, and management. As IR procedures continue to evolve and expand, understanding potential...
3.
Hall T, Temperley H, Mac Curtain B, OSullivan N, Quirke N, McEniff N, et al.
Surgeon
. 2024 Oct;
22(6):e213-e220.
PMID: 39414468
Introduction: Acute upper gastrointestinal bleeding (UGIB) secondary to gastric cancer presents a significant clinical challenge due to its high morbidity and mortality rates. Transcatheter arterial embolisation (TAE) has emerged as...
4.
Temperley H, Mac Curtain B, OSullivan N, Mulhall C, Temperley T, Mehigan B, et al.
Curr Oncol
. 2024 Sep;
31(9):5151-5163.
PMID: 39330009
Background: We aim to ascertain prognostic factors in the current management of anal cancer within this study. Methods: We reviewed the management and outcomes of anal cancer cases over a...
5.
Salama M, ONeill M, Ryan E, OSullivan N, Nugent T, Temperley H, et al.
Diagnostics (Basel)
. 2024 Aug;
14(16).
PMID: 39202258
Introduction: Goblet cell carcinoid (GCC) is a rare and poorly understood appendiceal neoplasm, exhibiting mixed histological and aggressive clinical features. Current guidelines recommend right hemicolectomy in all cases, although there...
6.
OSullivan N, Temperley H, Horan M, Mac Curtain B, ONeill M, Donohoe C, et al.
Curr Probl Diagn Radiol
. 2024 Jul;
53(6):717-722.
PMID: 39025746
Introduction: Radiomics offers the potential to predict oncological outcomes from pre-operative imaging in order to identify 'high risk' patients at increased risk of recurrence. The application of radiomics in predicting...
7.
OSullivan N, Temperley H, Kyle E, Sweeney K, ONeill M, Gilham C, et al.
Int J Colorectal Dis
. 2024 May;
39(1):82.
PMID: 38809315
Introduction: Circulating tumour DNA (ctDNA) has emerged as a promising biomarker in various cancer types, including locally advanced rectal cancer (LARC), offering potential insights into disease progression, treatment response and...
8.
OSullivan N, Temperley H, Horan M, Kamran W, Corr A, OGorman C, et al.
Abdom Radiol (NY)
. 2024 May;
49(10):3540-3547.
PMID: 38744703
Ovarian cancer is associated with high cancer-related mortality rate attributed to late-stage diagnosis, limited treatment options, and frequent disease recurrence. As a result, careful patient selection is important especially in...
9.
OSullivan N, Temperley H, Larkin J, McCormick J, Rausa E, McCormick P, et al.
Int J Colorectal Dis
. 2024 May;
39(1):71.
PMID: 38724801
Introduction: Robotic transanal minimally invasive surgery (R-TAMIS) was introduced in 2012 for the excision of benign rectal polyps and low grade rectal cancer. Ergonomic improvements over traditional laparoscopic TAMIS (L-TAMIS)...
10.
Temperley H, Fannon T, OSullivan N, ONeill M, Mac Curtain B, Gilham C, et al.
Int J Mol Sci
. 2024 Apr;
25(7).
PMID: 38612815
This systematic review investigates the potential of circulating tumour DNA (ctDNA) as a predictive biomarker in the management and prognosis of squamous cell carcinoma of the anal canal (SCCA). PubMed,...